| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 12/24/1997 | WO1997048443A1 Iontophoretic delivery of cell adhesion inhibitors |
| 12/24/1997 | WO1997048408A2 Method for the prevention and treatment of mastitis |
| 12/24/1997 | WO1997048401A1 Deoxy and oxygen-substituted sugar-containing 14-aminosteroid compounds for use as an antiarrhythmic |
| 12/24/1997 | WO1997048400A1 Hydroxy-phosphinyl derivatives useful as naaladase inhibitors |
| 12/24/1997 | WO1997048399A1 Certain phosphinyl derivatives useful as naaladase inhibitors |
| 12/24/1997 | WO1997048398A1 Liposome preparations of indolocarbazole derivatives |
| 12/24/1997 | WO1997048397A1 Use of pyridyl alkane, pyridyl alkene and/or pyridyl alkine acid amides in the treatment of tumors or for immunosuppression |
| 12/24/1997 | WO1997048396A1 A method of treating liver disease and like indications with vasodilating agents |
| 12/24/1997 | WO1997048395A1 Iontophoretic delivery of integrin inhibitors |
| 12/24/1997 | WO1997048394A1 Combination of ropinirole and l-dopa for use in the treatment of parkinson's disease |
| 12/24/1997 | WO1997048393A1 Use of green porphyrins in the manufacture of a medicament in the treatment of atherosclerosis without purposeful irradiation of the porphyrin derivatives |
| 12/24/1997 | WO1997048391A2 Methods and compositions comprising r-ibuprofen |
| 12/24/1997 | WO1997048390A1 Analgesics combining acetaminophen with meclizine |
| 12/24/1997 | WO1997048389A1 2-cyclopenten-1-one as an inducer of hsp70 |
| 12/24/1997 | WO1997048388A1 Method of retarding and ameliorating central nervous system and eye damage |
| 12/24/1997 | WO1997048387A1 Device for topical treatment of acne and its method of manufacture |
| 12/24/1997 | WO1997048386A1 Enteric coated diltiazem once-a-day formulation |
| 12/24/1997 | WO1997048385A2 Controlled release tablet |
| 12/24/1997 | WO1997048383A1 Biconvex rapidly disintegrating dosage forms |
| 12/24/1997 | WO1997048382A2 Multiple-unit type prolonged action drug preparation |
| 12/24/1997 | WO1997048380A1 ADMINISTRATION REGIMEN OF H+, K+-ATPase INHIBITORS |
| 12/24/1997 | WO1997048379A1 Nasal administration of desmopressin |
| 12/24/1997 | WO1997048376A1 Clear cosmetic sticks and process for its preparation |
| 12/24/1997 | WO1997048371A1 Topical product formulations containing strontium for reducing skin irritation |
| 12/24/1997 | WO1997048369A2 Prophylactic and therapeutic treatment of skin sensitization and irritation |
| 12/24/1997 | WO1997048368A2 Naphthyridines which affect il-4 and g-csf |
| 12/24/1997 | WO1997048367A2 Compositions for the treatment of chronic infections containing glucocorticoid and antiglucocorticoid |
| 12/24/1997 | WO1997048278A1 Antifungal activity of the spongistatins |
| 12/24/1997 | WO1997048274A1 A method for minimizing the uterotrophic effect of droloxifene |
| 12/24/1997 | WO1997042941A3 Buccal delivery system |
| 12/24/1997 | WO1997041230A3 Cc-type chemokines |
| 12/24/1997 | WO1997040824A3 Propellant mixtures and aerosols for micronising medicaments with compressed gas |
| 12/24/1997 | WO1997040073A3 Biologically active protein (collagen fragment hf-coll-18/514cf) for inhibiting the growth of tumours and capillary profilerations |
| 12/24/1997 | WO1997040006A3 Phosphate mimics |
| 12/24/1997 | WO1997038699A3 Use of alkylaryl polyether alcohol polymers for the treatment of chronic pulmonary inflammation |
| 12/24/1997 | WO1997036588A3 Use of 1,1-dialkyl-1,2,3,4-tetrahydroisoquinolines for the manufacture of a medicament for the treatment of psychosis and pain |
| 12/24/1997 | WO1997036497A3 Cocoa extract compounds and methods for making and using the same |
| 12/24/1997 | WO1997034594A3 Use of allosteric haemoglobin modifier for treating solid tumors and inhibiting tumor metastases |
| 12/24/1997 | WO1997025333A3 Macrocyclic compounds made from suboxide units |
| 12/24/1997 | CN1168696A RNA component of telomerase |
| 12/24/1997 | CN1168675A New compound |
| 12/24/1997 | CN1168672A 2,7-substituierte octahydro-1H-pyrido £1,2-A| pyrazin derivate |
| 12/24/1997 | CN1168670A 1,2,3,4-tetrahydroquinoxalindione derivative |
| 12/24/1997 | CN1168667A Pyridopyrimidones, quinolines and fused N-heretocycles as bradykinin antagonists |
| 12/24/1997 | CN1168662A Asiatic acid derivatives its manufacturing method and dermatological agent containing it |
| 12/24/1997 | CN1168634A Kit for osteoporosis treatment cycle |
| 12/24/1997 | CN1168633A Boronic ester and acid compounds, synthesis and uses |
| 12/24/1997 | CN1168632A Antineoplastic cocoa extracts, method for making, using |
| 12/24/1997 | CN1168631A Methods for treating resistant tumors |
| 12/24/1997 | CN1168379A Extraction of biological active organic silicon compounds of seaweed origin |
| 12/24/1997 | CN1168377A Novel buprenophine analgesic analogues |
| 12/24/1997 | CN1168376A Process for preparing sildenafil |
| 12/24/1997 | CN1168373A Estrogenic agents |
| 12/24/1997 | CN1168372A 1, 2-diphenylpyrrole derivatives, their preparation and their therapeutic uses |
| 12/24/1997 | CN1168275A External-use drug for furunculosis |
| 12/24/1997 | CN1168273A 蜂蛹钙制剂 Pupae calcium preparations |
| 12/24/1997 | CN1168270A Analgosic |
| 12/24/1997 | CN1168269A External-use anti-cancer ointment |
| 12/24/1997 | CN1036779C Aryl naphthenes derivant and its use |
| 12/24/1997 | CN1036763C Pharmaceutical composition pharmaceutical granulate and process for their preparation |
| 12/24/1997 | CA2258919A1 Methanesulphonate salt of an arylpiperazine derived from tryptamine and its solvates for pharmaceutical use |
| 12/24/1997 | CA2258822A1 Compounds and methods for providing pharmacologically active preparations and uses thereof |
| 12/24/1997 | CA2258736A1 Prophylactic and therapeutic treatment of skin sensitization and irritation |
| 12/24/1997 | CA2258726A1 Topical product formulations containing strontium for reducing skin irritation |
| 12/24/1997 | CA2258709A1 Controlled release tablet |
| 12/24/1997 | CA2258696A1 A method of treating liver disease and like indications with vasodilating agents |
| 12/24/1997 | CA2258589A1 Certain phosphinyl derivatives useful as naaladase inhibitors |
| 12/24/1997 | CA2258587A1 Hydroxy-phosphinyl derivatives useful as naaladase inhibitors |
| 12/24/1997 | CA2258559A1 Indoline derivatives useful as 5-ht-2c receptor antagonists |
| 12/24/1997 | CA2258556A1 Drug resistance and multidrug resistance modulators |
| 12/24/1997 | CA2258552A1 Nasal administration of desmopressin |
| 12/24/1997 | CA2258536A1 Heterocyclylmethylamino derivatives of cyclobutene-3,4-diones as potassium channel modulators |
| 12/24/1997 | CA2258313A1 Substituted tetrahydronaphthalene and dihydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity |
| 12/24/1997 | CA2258247A1 Sulphonamide derivatives and their use in the treatment of cns disorders |
| 12/24/1997 | CA2258242A1 Device for topical treatment of acne and its method of manufacture |
| 12/24/1997 | CA2258240A1 Indoline derivatives useful as 5-ht-2c receptor antagonists |
| 12/24/1997 | CA2258238A1 Substituted benzamide derivatives and their use as anticonvulsants |
| 12/24/1997 | CA2258202A1 Deoxy and oxygen-substituted sugar-containing 14-aminosteroid compounds for use as an antiarrhythmic |
| 12/24/1997 | CA2257962A1 Compounds having effects on serotonin-related systems |
| 12/24/1997 | CA2257855A1 Human thymosin .beta.15 gene, protein and uses thereof |
| 12/24/1997 | CA2257834A1 Polynucleotides encoding secreted proteins |
| 12/24/1997 | CA2257564A1 Use of green porphyrins in the manufacture of a medicament in the treatment of atherosclerosis without purposeful irradiation of the porphyrin derivatives |
| 12/24/1997 | CA2257535A1 A method for minimizing the uterotrophic effect of droloxifene |
| 12/24/1997 | CA2257528A1 Human protein kinase c inhibitor homolog |
| 12/24/1997 | CA2257405A1 Administration regimen of h+, k+-atpase inhibitors |
| 12/24/1997 | CA2257361A1 Macrocyclic 13-membered ring derivatives of erythromycins a and b |
| 12/24/1997 | CA2257289A1 Clear cosmetic sticks and process for its preparation |
| 12/24/1997 | CA2257130A1 Human camp-dependent protein kinase inhibitor homolog |
| 12/24/1997 | CA2253835A1 Process for the preparation of chiral keto-heterocycles of basic amino acids |
| 12/24/1997 | CA2251779A1 Method for the prevention and treatment of mastitis |
| 12/24/1997 | CA2246751A1 Human metabotropic glutamate receptor |
| 12/23/1997 | US5700948 Pyrrolidine compounds and process of preparing |
| 12/23/1997 | US5700947 Having reduced side effects |
| 12/23/1997 | US5700933 3(2-oxazolidinone-3-yl)-2-azetidinone-1-acetic acid or ester for making carbacephalosporins antibiotics |
| 12/23/1997 | US5700928 Polynucleotide encoding saliva binding protein |
| 12/23/1997 | US5700922 PNA-DNA-PNA chimeric macromolecules |
| 12/23/1997 | US5700920 Carbocyclic nucleosides containing bicyclic rings, oligonucleotides therefrom, process for their preparation, their use and intermediates |
| 12/23/1997 | US5700907 Nucleotide sequences coding for variable regions of β chains of human T lymphocyte receptors, corresponding peptide segments and the diagnostic and therapeutic uses |
| 12/23/1997 | US5700839 Antiarrythmia agents; act as inhibitors of the cellular na+/h+ antiporter |
| 12/23/1997 | US5700838 Hydroxamic acid derivatives as metalloproteinase inhibitors |